These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29886488)
1. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review. Baltatzis M; Siriwardena AK Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488 [TBL] [Abstract][Full Text] [Related]
2. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. Dutton SJ; Kenealy N; Love SB; Wasan HS; Sharma RA; BMC Cancer; 2014 Jul; 14():497. PubMed ID: 25011439 [TBL] [Abstract][Full Text] [Related]
3. Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma. Feng X; Zhang L; Niu H; Zhang H; Yang L; Wen Y; Chen SY; Shi Y; He Z; Yu L; Wang Y; Huang X; Wang Z; Qin M; Wen X; Zhang Z; Song J; Zheng Z; Yin H; Zhang H; Ma L; Wei J; Wu X; Zhang L; Zhao Y; Lu Q; Xiao H; Liu T; Fang P; Wei L; Gandhi RT; Dong J Asia Pac J Clin Oncol; 2024 Apr; 20(2):319-322. PubMed ID: 36658669 [TBL] [Abstract][Full Text] [Related]
4. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. Virdee PS; Moschandreas J; Gebski V; Love SB; Francis EA; Wasan HS; van Hazel G; Gibbs P; Sharma RA JMIR Res Protoc; 2017 Mar; 6(3):e43. PubMed ID: 28351831 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of Abbott EM; Falzone N; Lee BQ; Kartsonaki C; Winter H; Greenhalgh TA; McGowan DR; Syed N; Denis-Bacelar AM; Boardman P; Sharma RA; Vallis KA J Nucl Med; 2020 Nov; 61(11):1658-1664. PubMed ID: 32358093 [TBL] [Abstract][Full Text] [Related]
6. [Expert consensus on the standardized procedure of selective internal radiation therapy with Yttrium-90 microspheres for liver malignancies (2024 edition)]. ; Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):486-498. PubMed ID: 38317360 [TBL] [Abstract][Full Text] [Related]
7. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. Kennedy A; Brown DB; Feilchenfeldt J; Marshall J; Wasan H; Fakih M; Gibbs P; Knuth A; Sangro B; Soulen MC; Pittari G; Sharma RA J Gastrointest Oncol; 2017 Dec; 8(6):1079-1099. PubMed ID: 29299370 [TBL] [Abstract][Full Text] [Related]
8. Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy. Hosseini Shabanan S; Nezami N; Abdelsalam ME; Sheth RA; Odisio BC; Mahvash A; Habibollahi P Curr Oncol; 2022 May; 29(6):3825-3848. PubMed ID: 35735415 [TBL] [Abstract][Full Text] [Related]
9. Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities. Karaoğlan BB; Öz DK; Araz MS; Akyol C; Utkan G Curr Oncol Rep; 2024 Jul; 26(7):791-803. PubMed ID: 38776011 [TBL] [Abstract][Full Text] [Related]
11. Radioembolisation of liver metastases. Boshell D; Bester L J Med Imaging Radiat Oncol; 2023 Dec; 67(8):842-852. PubMed ID: 37343147 [TBL] [Abstract][Full Text] [Related]
12. Liver Transplantation for Colorectal Liver Metastases: Is It Appropriate? Whitrock JN; Hartman SJ; Quillin RC; Shah SA Adv Surg; 2023 Sep; 57(1):171-185. PubMed ID: 37536852 [TBL] [Abstract][Full Text] [Related]
13. Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry. Lee RC; Liang PC; Liang HL; Chen YF; Yu CY; Cheng PN; Hung CF; Hsia CY; Lai HC; Ho MC; Cheng YF; Liu YS; Chao Y; Chen CH J Gastroenterol Hepatol; 2024 Jul; 39(7):1318-1327. PubMed ID: 38615197 [TBL] [Abstract][Full Text] [Related]
14. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. Teo JY; Allen JC; Ng DC; Choo SP; Tai DW; Chang JP; Cheah FK; Chow PK; Goh BK HPB (Oxford); 2015 Oct; ():. PubMed ID: 26472490 [TBL] [Abstract][Full Text] [Related]
15. Optimizing unresectable colorectal liver metastases for surgery--no limits, any benefits? Gall TM; Frampton AE; Krell J; Jiao LR J Gastrointest Surg; 2013 Dec; 17(12):2185-7. PubMed ID: 23592187 [No Abstract] [Full Text] [Related]
16. Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy. Domouchtsidou A; Barsegian V; Mueller SP; Best J; Ertle J; Bedreli S; Horn PA; Bockisch A; Lindemann M Cancer Immunol Immunother; 2018 May; 67(5):843-853. PubMed ID: 29500633 [TBL] [Abstract][Full Text] [Related]
17. Selective internal radiation therapy for liver tumours. Sundram FX; Buscombe JR Clin Med (Lond); 2017 Oct; 17(5):449-453. PubMed ID: 28974597 [TBL] [Abstract][Full Text] [Related]
18. SIRT and chemotherapy in unresectable iCCA: Ready to take off. Bargellini I; Rimassa L; Masi G Hepatology; 2024 Jan; 79(1):9-11. PubMed ID: 37979204 [No Abstract] [Full Text] [Related]
19. Transarterial Selective Internal Radiation Therapy with Yttrium-90 for Liver Metastatic Urothelial Carcinoma of the Ureter as a Bridging Therapy to Immunotherapy: A Case Report with a 10-Year Follow-Up. Schmid BP; Silva Cunha MJ; Moreira Valle LG; Galastri FL; Affonso BB; Falsarella PM; Kaliks Guendelmann RA; Garcia RG; Nasser F Case Rep Oncol; 2023; 16(1):711-717. PubMed ID: 37933309 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective Analysis. Yeakel J; Seyedin SN; Harada G; Hagopian G; Mahmood S; Bennett R; Harris JP; Abbott EM; Lindner S; Dayyani F; Sehgal V; Kuo JV; Abi-Jaoudeh N Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]